Besides 2-DG, tamoxifen, an inhibitor of estrogen receptor (ER) often used for treatment of ER-positive breast and ovarian cancers [59,60] has also been shown to be potentially useful for improving ovarian aging. This evidence concerns the gene ESR1 and ovarian cancer.